AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12855928
Drug: Exercise and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise and diuretic (EXDI)
Trial: 11239617
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg oral mifepristone followed by 800 microg vaginal misoprostol at 24, 48, or 72 h
Trial: 1355209
Drug: High energy
RxNorm normalized name: High energy formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High energy supplement (HE) providing 1950 kJ (465 kcal) during the last trimester of pregnancy
Trial: 1355209
Drug: Low energy
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low energy supplement (LE) providing 218 kJ (52 kcal) during the last trimester of pregnancy
Trial: 1355209
Drug: High energy
RxNorm normalized name: High energy formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High energy supplement (HE)
Trial: 6347428
Drug: Aspirin alone
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin alone (975 mg/day)
Trial: 6347428
Drug: Aspirin and
RxNorm normalized name: Aspirin and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and dipyridamole (225 mg/day)
Trial: 30352778
Drug: Placebo (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (4 g olive oil)
Trial: 19291926
Drug: Betamethasone injection
RxNorm normalized name: Betamethasone
DrugBank: Betamethasone phosphate (DB14669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone injection (Group A)
Trial: 19291926
Drug: Non-steroidal anti-inflammatory
RxNorm normalized name: Non-steroidal anti-inflammatory agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-steroidal anti-inflammatory drugs (NSAIDs) (Group B)
Trial: 9802368
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide turbohaler (1600 micrograms)
Trial: 15136063
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Probucol and Ticlopidine)
Trial: 11214732
Drug: Seal oil
RxNorm normalized name: seal oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seal oil (SO) 15 mL daily for 14 months
Trial: 11214732
Drug: Cod-liver oil
RxNorm normalized name: Cod-liver oil
DrugBank: Cod liver oil (DB11321)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cod-liver oil (CLO) 15 mL daily for 14 months
Trial: 3400902
Drug: Oral methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral methylprednisolone (Medrol tablets, Upjohn)
Trial: 3400902
Drug: Topical vasoconstrictor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical vasoconstrictor (oxymetazoline spray)
Trial: 26681272
Drug: TachoSil patch
RxNorm normalized name: fibrinogen / thrombin Medicated Patch [TachoSil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TachoSil patch
Trial: 26681272
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no TachoSil patch)
Trial: 24275775
Drug: Mepivacaine 2%
RxNorm normalized name: mepivacaine 2% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepivacaine 2% with epinephrine (10 µg/mL), injected at 5.4 mL (54 µg epinephrine) for group I and 10.8 mL (108 µg epinephrine) for group II.
Trial: 24275775
Drug: Mepivacaine 2%
RxNorm normalized name: mepivacaine 2% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepivacaine 2% with epinephrine (108 µg) in group II.
Trial: 24275775
Drug: Mepivacaine 2%
RxNorm normalized name: mepivacaine 2% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepivacaine 2% with epinephrine (54 µg) in group I.
Trial: 23676529
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy + Selective Serotonin Reuptake Inhibitor (CBT+SSRI)
Trial: 20639274
Drug: Intensive lifestyle
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive lifestyle programme (e.g. physical exercise, smoking cessation, dietary advice, including stress management)
Trial: 16603428
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist (flare-up) protocol
Trial: 7824809
Drug: Formoterol, inhaled,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol, inhaled, twice daily for 12 weeks
Trial: 7824809
Drug: Salbutamol, inhaled,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol, inhaled, four times daily for 12 weeks
Trial: 28456146
Drug: Polypodium leucotomos/pomegranate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polypodium leucotomos/pomegranate combination (PPmix®) 480 mg/day
Trial: 28456146
Drug: Polypodium leucotomos
RxNorm normalized name: Polypodium leucotomos
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polypodium leucotomos alone (Fernblock®) 480 mg/day
Trial: 26297156
Drug: GnRH agonists
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonists (triptorelin injections of 0.1mg on the 4th and 6th day after progesterone introduction)
Trial: 23663119
Drug: Resveratrol supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resveratrol supplementation (150 mg/day)
Trial: 21724628
Drug: Daily interruption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily interruption of fentanyl and/or midazolam infusions for up to 6 hours
Trial: 16961787
Drug: Topiramate (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (25 mg to 100 mg daily, titrated by week 4)
Trial: 3531295
Drug: Captopril 25
RxNorm normalized name: captopril 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 25 mg plus hydrochlorothiazide 15 mg
Trial: 28708420
Drug: 1.5 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g/kg BW Tualang Honey (high honey; HH; n=10)
Trial: 28708420
Drug: 0.75 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75 g/kg BW Tualang Honey (low honey; LH; n=10)
Trial: 22804826
Drug: Quadriderm cream
RxNorm normalized name: Cuadriderma
DrugBank: Polymyxin B (DB00781)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quadriderm cream
Trial: 18217459
Drug: Rice policosanol
RxNorm normalized name: POLICOSANOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rice policosanol 10 mg/day
Trial: 9549666
Drug: Modafinil and
RxNorm normalized name: Modafinil
DrugBank: Modafinil (DB00745)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Modafinil and Methylphenidate (combination)
Trial: 8045961
Drug: Goserelin (GnRH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin (GnRH agonist) for 9 months
Trial: 2648890
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium 100 mg suppository
Trial: 29738179
Drug: Gujing Maisiha
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gujing Maisiha Tablets combined with natural vitamin E
Trial: 16828803
Drug: D-cycloserine (DCS)
RxNorm normalized name: D-Cycloserine
DrugBank: Cycloserine (DB00260)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: D-cycloserine (DCS) 50 or 500 mg
Trial: 15176649
Drug: Etanercept 25
RxNorm normalized name: etanercept 25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 25 mg subcutaneously twice weekly for 12 weeks
Trial: 2285719
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline epidural solution
Trial: 31140402
Drug: Early endovenous
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early endovenous ablation (compression therapy and superficial endovenous ablation within 2 weeks of randomisation)
Trial: 31140402
Drug: Deferred endovenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferred endovenous ablation (compression therapy followed by endovenous ablation once the ulcer had healed)
Trial: 24356398
Drug: Full periodontal
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Full periodontal therapy (Group 1, n = 15)
Trial: 17945291
Drug: Desmopressin combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desmopressin combined with 0.5 mg/kg furosemide daily
Trial: 10190788
Drug: Paclitaxel 1-hour
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 1-hour infusion
Trial: 10190788
Drug: Paclitaxel 3-hour
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 3-hour infusion
Trial: 31460771
Drug: Panchatikta Ghrita
RxNorm normalized name: Ghrita Kumari Flower
DrugBank: Aloe vera flower (DB14254)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Panchatikta Ghrita (PG) with calcium and vitamin D3 supplements
Trial: 31460771
Drug: Calcium and
RxNorm normalized name: Calcium and Magnesium
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium and vitamin D3 supplements
Trial: 28510346
Drug: Rivipansel 4
RxNorm normalized name: Rivipansel
DrugBank: Rivipansel (DB12778)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivipansel 4 g by intravenous infusion over 20 minutes
Trial: 19906312
Drug: Multi-disciplinary orientation
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-disciplinary orientation program including face-to-face introduction to hospital facilities, multi-disciplinary team, treatment side effects, and self-care strategies.
Trial: 16984385
Drug: DN-101 (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DN-101 (high dose calcitriol) with docetaxel
Trial: 15259289
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg 17beta-estradiol combined with 1, 2 or 3 mg drospirenone daily
Trial: 15259289
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg drospirenone
Trial: 10790458
Drug: Asthma education
RxNorm normalized name: epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Asthma education and medical treatment in the setting of a tertiary care pediatric allergy clinic with monthly contact from an asthma outreach nurse.
Trial: 8379858
Drug: Estradiol gel
RxNorm normalized name: ESTRADIOL 1 mg in 1 g TOPICAL GEL [Estradiol Gel]
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol gel (1.25 g)
Trial: 8379858
Drug: Estradiol gel
RxNorm normalized name: ESTRADIOL 1 mg in 1 g TOPICAL GEL [Estradiol Gel]
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol gel (2.5 g)
Trial: 29354970
Drug: Acupuncture at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture at the twelve jing-well points (20 treatments, once a day) combined with bladder function training
Trial: 29354970
Drug: Routine clinical
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine clinical medication and bladder function training
Trial: 21698665
Drug: 100 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 µg of 17β-estradiol (with cyclic progesterone) transdermally for 18 months
Trial: 21698665
Drug: Incremental low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Incremental low-dose oral ethinyl-estradiol (3.75 µg daily from 0 to 6 months, 7.5 µg from 6 to 12 months, 11.25 µg from 12 to 18 months)
Trial: 1385295
Drug: Isoprinosine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoprinosine (500 mg twice daily)
Trial: 18444146
Drug: 400-mcg/day of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400-mcg/day of Se
Trial: 18444146
Drug: 200-mcg/day of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200-mcg/day of Se
Trial: 16490580
Drug: Sitagliptin 25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin 25, 50, 100, 200, or 400 mg QD for 10 days
Trial: 16490580
Drug: Sitagliptin 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin 800 mg on day 1 followed by 600 mg QD on days 3 to 10
Trial: 16490580
Drug: Sitagliptin 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin 300 mg BID for 10 days
Trial: 11368283
Drug: Topical corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical corticosteroids (e.g., betamethasone sodium phosphate, beclomethasone dipropionate, fluticasone propionate, budesonide)
Trial: 11368283
Drug: Topical corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical corticosteroids (e.g., beclomethasone dipropionate, flunisolide, budesonide)
Trial: 2458659
Drug: Epidural analgesia
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural analgesia + assumed blockade of prostaglandin synthesis, blockade of receptors for histamine1, histamine2 and serotonin2, and inhibition of fibrinolysis with indomethacin, astemizole, ranitidine, ketanserin and tranexamic acid
Trial: 25496342
Drug: Tai Chi
RxNorm normalized name: Ma Chi Xian
DrugBank: Purslane (DB14327)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tai Chi combined with conventional rehabilitation therapies
Trial: 25496342
Drug: Standard conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard conventional rehabilitation therapies
Trial: 22825094
Drug: Self-administered misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered misoprostol (400 μg vaginally or buccally 3-4 hours before IUD insertion)
Trial: 22825094
Drug: Self-administered misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered misoprostol
Trial: 18996858
Drug: Cyclosporine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine (2.5 mg x kg(‐1)d(‐1)) plus low-calorie diet
Trial: 16186076
Drug: black cohosh
RxNorm normalized name: black cohosh
DrugBank: Black cohosh (DB13975)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: black cohosh 160 mg daily
Trial: 16186076
Drug: multibotanical (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: multibotanical (50 mg black cohosh, alfalfa, chaste tree, dong quai, false unicorn, licorice, oats, pomegranate, Siberian ginseng, boron) four capsules daily
Trial: 16186076
Drug: conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: conjugated equine estrogen 0.625 mg +/- 2.5 mg medroxyprogesterone acetate
Trial: 12517545
Drug: Morphine sulphate
RxNorm normalized name: Morphine sulphate
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine sulphate (MS)
Trial: 1325853
Drug: AVP antagonist
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: AVP antagonist (10 micrograms/kg body weight i.v.)
Trial: 1325853
Drug: Nicotine infusion
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine infusion (1.0 micrograms/kg body weight per min)
Trial: 1325853
Drug: AVP antagonist
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: AVP antagonist (5 micrograms/kg i.v.)
Trial: 1325853
Drug: Nicotine infusion
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine infusion plus AVP antagonist i.v.
Trial: 6238558
Drug: Metaproterenol (MP)
RxNorm normalized name: MP-0250
DrugBank: MP-0250 (DB17218)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metaproterenol (MP) 1.5 mg four times a day
Trial: 27007793
Drug: Alternative antihypertensive
RxNorm normalized name: yellow fever virus strain 17D-204 live antigen
DrugBank: Yellow fever vaccine (DB10805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternative antihypertensive regimen
Trial: 20154294
Drug: Developmental formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Developmental formulations of paracetamol (acetaminophen)
Trial: 20154294
Drug: Commercial products
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Commercial products of paracetamol (acetaminophen)
Trial: 20154294
Drug: All formulations
RxNorm normalized name: Novel Influenza-H1N1-09, all formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All formulations (developmental and commercial)
Trial: 10472325
Drug: Acyclovir (ACV)
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acyclovir (ACV) 15 mg/kg i.v. over one hour every 8 hours for 42 doses
Trial: 10472325
Drug: Valacyclovir (VCV)
DrugBank: Valaciclovir (DB00577)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Valacyclovir (VCV) 2 g every 8 hours for a total of 42 doses (after switching from ACV)
Trial: 3908330
Drug: Aluminum ibuprofen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aluminum ibuprofen suspension (200 mg)
Trial: 3908330
Drug: Acetaminophen with
RxNorm normalized name: acetaminophen with codeine ORAL ELIXIR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen with codeine elixir (240 mg and 24 mg)
Trial: 26679630
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (5 capsules daily providing 2.0 g/d EPA and 1.0 g/d DHA)
Trial: 15755229
Drug: Physical activity
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical activity treatment
Trial: 12460128
Drug: Cannabis abuse
RxNorm normalized name: Medical Cannabis
DrugBank: Medical Cannabis (DB14009)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cannabis abuse treatment
Trial: 29804294
Drug: 10-day high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day high-dose proton pump inhibitor triple therapy (HD-PPI-TT) with 60 mg lansoprazole, 500 mg clarithromycin, and 1 g amoxicillin, each administered twice daily for 10 days
Trial: 29804294
Drug: 10-day sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day sequential therapy (ST) with 30 mg lansoprazole and 1 g amoxicillin for 5 days followed by 30 mg lansoprazole, 500 mg clarithromycin, and 400 mg metronidazole for 5 days
Trial: 29804294
Drug: 10-day high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day high-dose proton pump inhibitor triple therapy (HD-PPI-TT)
Trial: 23241449
Drug: Double-masked supplementation
RxNorm normalized name: MASK
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Double-masked supplementation with either 30 mg Fe and 400 μg folic acid or 60 mg Fe and 400 μg folic acid
Trial: 23888001
Drug: Prior treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prior treatment with antipsychotic long-acting injection (LAI)
Trial: 23888001
Drug: Clozapine (as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clozapine (as a randomised treatment)
Trial: 23888001
Drug: Non-clozapine oral
RxNorm normalized name: Clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Non-clozapine oral SGA (as a randomised treatment)
Trial: 23888001
Drug: Switch from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Switch from LAI to oral antipsychotic
Trial: 16729916
Drug: Cilengitide at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilengitide at 2000 mg in patients with nonmetastatic androgen-independent prostate cancer
Trial: 16729916
Drug: Cilengitide at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cilengitide at 500 mg or 2000 mg, intravenously twice weekly in patients with metastatic prostate cancer
Trial: 23165810
Drug: NaCl solution
RxNorm normalized name: sodium chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NaCl solution (Placebo)
Trial: 18598095
Drug: Acetyl-L-carnitine (ALC)
RxNorm normalized name: acetyl-L-carnitine
DrugBank: Acetylcarnitine (DB08842)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-L-carnitine (ALC) 1180 mg/day
Trial: 18598095
Drug: Thioctic acid
RxNorm normalized name: Thioctic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thioctic acid 600 mg/day
Trial: 15842525
Drug: Metformin 1
RxNorm normalized name: metformin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 1 g orally
Trial: 12160589
Drug: Alternating instillations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternating instillations of interferon‐alpha and BCG monthly for up to 1 year
Trial: 25220046
Drug: Weight reduction
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight reduction programme (group therapy with a 5-day educational intervention and five 2-hour follow-up visits)
Trial: 15081141
Drug: Riboflavin-containing microballoons
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Riboflavin-containing microballoons (MB) administered orally
Trial: 12171452
Drug: Calcium supplement
RxNorm normalized name: Calcium supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplement containing 1,000 mg supplemental calcium as calcium citrate malate (n=7)